Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine

Neurotoxicology and Teratology

Volumn 31, Issue 3, 2009, Pages 177-182

  Paz, Monica S ^a   Smith, Lynne M ^a   LaGasse, Linda L ^b   Derauf, Chris ^c   Grant, Penny ^d   Shah, Rizwan ^e   Arria, Amelia ^f   Huestis, Marilyn ^g   Haning, William ^c   Strauss, Arthur ^h   Grotta, Sheri Della ^b   Liu, Jing ^b   Lester, Barry M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

^e Blank Children's Hospital   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^h LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Depression; Drugs; Neurodevelopment; Prenatal exposure

Indexed keywords

ALCOHOL; CANNABIS; METHAMPHETAMINE;

AROUSAL; ARTICLE; CHILD WELFARE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INFORMED CONSENT; LETHARGY; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPOTONIA; NERVE CELL DIFFERENTIATION; NEWBORN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RATING SCALE; SCREENING; TOBACCO;

AROUSAL; DEPRESSION; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LETHARGY; METHAMPHETAMINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PUERPERAL DISORDERS;

EID: 64749088628     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2008.11.004     Document Type: Article

References (60)

1. Abrams S.M., Field T., Scafidi F., and Prodromidis M. Maternal "depression" effects on infants' Brazelton scale performance. Infant Ment. Health J. 16 (1995) 231-235
2. Alder J., Fink N., Bitzer J., Hosli I., and Holzgreve W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J. Matern. Fetal Neonatal. Med. 20 (2007) 189-209
3. Altshuler L.L., Hendrick V., and Cohen L.S. An update on mood and anxiety disorders during pregnancy and the postpartum period. Prim. Care Companion J Clin. Psychiat. 2 (2000) 217-222
4. Arria A.M., Derauf C., LaGasse L.L., Grant P., Shah R., Smith L., Haning W., Huestis M., Strauss A., Grotta S.D., Liu J., and Lester B. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern. Child Health J. (2006) 1-10
5. Bauer C.R., Shankaran S., Bada H.S., Lester B., Wright L.L., Krause-Steinrauf H., Smeriglio V.L., Finnegan L.P., Maza P.L., and Verter J. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am. J. Obstet. Gynecol. 186 (2002) 487-495
6. Bennett H.A., Einarson A., Taddio A., Koren G., and Einarson T.R. Prevalence of depression during pregnancy: systematic review. Obstet. Gynecol. 103 (2004) 698-709
7. Billing L., Eriksson M., Steneroth G., and Zetterstrom R. Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy. Child Abuse Negl. 12 (1988) 503-507
8. Boddiger D. Metamphetamine use linked to rising HIV transmission. Lancet 365 (2005) 1217-1218
9. Bowen A., and Muhajarine N. Antenatal depression. Can. Nurse 102 (2006) 26-30
10. Brazelton T.B. Neonatal Behavioral Assessment Scale (1984), JB Lippinicott, Philadelphia, PA
11. Coyle M.G., Ferguson A., Lagasse L., Liu J., and Lester B. Neurobehavioral effects of treatment for opiate withdrawal. Arch. Dis. Child Fetal Neonatal. Ed. 90 (2005) F73-F74
12. Da Costa D., Larouche J., Dritsa M., and Brender W. Psychosocial correlates of prepartum and postpartum depressed mood. J. Affect. Disord. 59 (2000) 31-40
13. Davidson R.J. Affective style, psychopathology, and resilience: brain mechanisms and plasticity. Am. Psychol. 55 (2000) 1196-1214
14. Diego M.A., Field T., Hernandez-Reif M., Cullen C., Schanberg S., and Kuhn C. Prepartum, postpartum, and chronic depression effects on newborns. Psychiatry 67 (2004) 63-80
15. Dieter J.N., Field T., Hernandez-Reif M., Jones N.A., Lecanuet J.P., Salman F.A., and Redzepi M. Maternal depression and increased fetal activity. J. Obstet. Gynaecol. 21 (2001) 468-473
16. Dixon S.D. Effects of transplacental exposure to cocaine and methamphetamine on the neonate. West J. Med. 150 (1989) 436-442
17. Evans J., Heron J., Francomb H., Oke S., and Golding J. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323 (2001) 257-260
18. Field T. Early interventions for infants of depressed mothers. Pediatrics 102 (1998) 1305-1310
19. Field T. Maternal depression effects on infants and early interventions. Prev. Med. 27 (1998) 200-203
20. Field T., Healy B., Goldstein S., Perry S., Bendell D., Schanberg S., Zimmerman E.A., and Kuhn C. Infants of depressed mothers show "depressed" behavior even with nondepressed adults. Child Dev. 59 (1988) 1569-1579
21. Field T., Diego M., Hernandez-Reif M., Salman F., Schanberg S., Kuhn C., Yando R., and Bendell D. Prenatal anger effects on the fetus and neonate. J. Obstet. Gynaecol. 22 (2002) 260-266
22. Field T., Diego M., Hernandez-Reif M., Schanberg S., Kuhn C., Yando R., and Bendell D. Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate. Depress. Anxiety. 17 (2003) 140-151
23. Field T., Diego M., and Hernandez-Reif M. Prenatal depression effects on the fetus and newborn: a review. Infant Behav. Dev. 29 (2006) 445-455
24. Finnegan L.P. Neonatal abstinence syndrome: assessment and pharmacotherapy. In: Rubatelli F.F., and Granati B. (Eds). Neonatal Therapy and Update (1986), Excerpta Medica, New York, NY
25. Fox N.A. Dynamic cerebral processes underlying emotion regulation. Monogr. Soc. Res. Child Dev. 59 (1994) 152-166
26. Gotlib I.H., Whiffen V.E., Mount J.H., Milne K., and Cordy N.I. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J. Consult Clin. Psychol. 57 (1989) 269-274
27. Halbreich U. Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and research. CNS Spectr. 9 (2004) 177-184
28. Hobfoll S.E., Ritter C., Lavin J., Hulsizer M.R., and Cameron R.P. Depression prevalence and incidence among inner-city pregnant and postpartum women. J. Consult Clin. Psychol. 63 (1995) 445-453
29. Hoffman S., and Hatch M.C. Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol. 19 (2000) 535-543
30. Hollins K. Consequences of antenatal mental health problems for child health and development. Curr. Opin. Obstet. Gynecol. 19 (2007) 568-572
31. Hurley K.M., Black M.M., Papas M.A., and Caufield L.E. Maternal symptoms of stress, depression, and anxiety are related to nonresponsive feeding styles in a statewide sample of WIC participants. J. Nutr. 138 (2008) 799-805
32. Inaba A., Thoits P.A., Ueno K., Gove W.R., Evenson R.J., and Sloan M. Depression in the United States and Japan: gender, marital status, and SES patterns. Soc. Sci. Med. 61 (2005) 2280-2292
33. Johnson R.E., Jones H.E., Jasinski D.R., Svikis D.S., Haug N.A., Jansson L.M., Kissin W.B., Alpan G., Lantz M.E., Cone E.J., Wilkins D.G., Golden A.S., Huggins G.R., and Lester B.M. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 63 (2001) 97-103
34. Kavanaugh M., McMillen R.C., Pascoe J.M., Hill S.L., Winickoff J.P., and Weitzman M. The co-occurrence of maternal depressive symptoms and smoking in a national survey of mothers. Ambul. Pediatr. 5 (2005) 341-348
35. Law K.L., Stroud L.R., LaGasse L.L., Niaura R., Liu J., and Lester B.M. Smoking during pregnancy and newborn neurobehavior. Pediatrics 111 (2003) 1318-1323
36. Lester B.M., Tronick E.Z., Lagasse L., Seifer R., Bauer C.R., Shankaran S., Bada H.S., Wright L.L., Smeriglio V.L., Lu J., Finnegan L.P., and Maza P.L. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 110 (2002) 1182-1192
37. Lester B.M., Tronick E.Z., and Brazelton T.B. The Neonatal Intensive Care Unit Network Neurobehavioral Scale procedures. Pediatrics 113 (2004) 641-667
38. Liu L., Li A., and Matthews S.G. Maternal glucocorticoid treatment programs HPA regulation in adult offspring: sex-specific effects. Am. J. Physiol Endocrinol. Metab 280 (2001) E729-E739
39. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., Bramen J., Shinn A.K., Miotto K., Learn J., Dong Y., Matochik J.A., Kurian V., Newton T., Woods R., Rawson R., and Ling W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch. Gen. Psychiatry 61 (2004) 73-84
40. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 9 (1992) 199-213
41. Napiorkowski B., Lester B.M., Freier M.C., Brunner S., Dietz L., Nadra A., and Oh W. Effects of in utero substance exposure on infant neurobehavior. Pediatrics 98 (1996) 71-75
42. Noble R.E. Depression in women. Metabolism 54 (2005) 49-52
43. O'Hara M.W. Social support, life events, and depression during pregnancy and the puerperium. Arch. Gen. Psychiatry 43 (1986) 569-573
44. Pajulo M., Savonlahti E., Sourander A., Helenius H., and Piha J. Antenatal depression, substance dependency and social support. J Affect. Disord. 65 (2001) 9-17
45. Ramchandani P., Stein A., Evans J., and O'Connor T.G. Paternal depression in the postnatal period and child development: a prospective population study. Lancet 365 (2005) 2201-2205
46. Righetti-Veltema M., Bousquet A., and Manzano J. Impact of postpartum depressive symptoms on mother and her 18-month-old infant. Eur. Child Adolesc. Psychiatry 12 (2003) 75-83
47. Rounsaville B.J., Kosten T.R., Weissman M.M., and Kleber H.D. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch. Gen. Psychiatry 43 (1986) 739-745
48. Ryan D., Milis L., and Misri N. Depression during pregnancy. Can. Fam. Physician 51 (2005) 1087-1093
49. Salisbury A.L., Lester B.M., Seifer R., Lagasse L., Bauer C.R., Shankaran S., Bada H., Wright L., Liu J., and Poole K. Prenatal cocaine use and maternal depression: effects on infant neurobehavior. Neurotoxicol. Teratol. (2006)
50. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., Takei N., and Mori N. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am. J. Psychiatry 158 (2001) 1206-1214
51. Singer L., Arendt R., Farkas K., Minnes S., Huang J., and Yamashita T. Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome. Dev. Psychopathol. 9 (1997) 473-489
52. Smith L., Yonekura M.L., Wallace T., Berman N., Kuo J., and Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J. Dev. Behav. Pediatr. 24 (2003) 17-23
53. Smith L.M., Lagasse L., Derauf C., Grant P., Shah R., Arria A., Huestis M., Haning W., Strauss A., Grotta S.D., Fallone M.D., Liu J., and Lester B. Prenatal methamphetmine use and neonatal neurobehavioral outcome: preliminary results from the Infant, Development, Environment, and Lifestyle (IDEAL) Study. Pediatr. Res. 55 (2004) 606A
54. Smith L.M., LaGasse L.L., Derauf C., Grant P., Shah R., Arria A., Huestis M., Haning W., Strauss A., Della G.S., Liu J., and Lester B.M. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118 (2006) 1149-1156
55. Smith L., Lagasse L., Derauf C., Grant P., Shah R., Arria A., Huestis M., Haning W., Strauss A., Grotta S.D., Fallone M.D., Liu J., and Lester B. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol. Teratol. 30 (2007) 20-28
56. Sohr-Preston S.L., and Scaramella L.V. Implications of timing of maternal depressive symptoms for early cognitive and language development. Clin. Child Fam. Psychol. Rev. 9 (2006) 65-83
57. Sommers I., Baskin D., and Baskin-Sommers A. Methamphetamine use among young adults: health and social consequences. Addict. Behav. (2005)
58. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2005 National Survey on Drug Use and Health: National Findings. NSDUH Series vol. H-30 (2006), Office of Applied Studies, Rockville, MD DHHS Publication No. SMA 06-4194, Ref Type: Report
59. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., and Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 158 (2001) 2015-2021
60. Zweben J.E., Cohen J.B., Christian D., Galloway G.P., Salinardi M., Parent D., and Iguchi M. Psychiatric symptoms in methamphetamine users. Am. J. Addict. 13 (2004) 181-190